New funding brings UKRI investment into the National Mouse Genetics Network to £25 million.
Age-related illnesses such as dementia are some of the most challenging disease areas we face. New UK Research and Innovation (UKRI) investment, confirmed today, will boost national commitments to understanding the causes of these diseases better and proposing new treatments, through research into model organisms such as mice.
The investment is part of the Securing Better Health, Ageing and Wellbeing strategic theme, one of five at the heart of UKRI’s current five-year strategy.
MRC (part of UKRI) has committed in excess of £20 million over five years to investigate key disease areas using the mouse as the main model organism. It harnesses the world-leading expertise across many disciplines and promotes better findings and outcomes through closer joint working.
